3-phenyllactic acid has been researched along with Mucormycosis in 1 studies
3-phenyllactic acid: alpha-hydroxy analog of phenylalanine; RN given refers to cpd without isomeric designation
3-phenyllactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.
Mucormycosis: Infection in humans and animals caused by any fungus in the order MUCORALES (e.g., RHIZOPUS; MUCOR; CUNNINGHAMELLA; APOPHYSOMYCES; ABSIDIA; SAKSENAEA and RHIZOMUCOR) There are many clinical types associated with infection including central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an OPPORTUNISTIC INFECTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lunavath, R | 1 |
Mohammad, SH | 1 |
Bhukya, KK | 1 |
Barigela, A | 1 |
Banoth, C | 1 |
Banothu, AK | 1 |
Bhukya, B | 1 |
1 other study available for 3-phenyllactic acid and Mucormycosis
Article | Year |
---|---|
Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated mucormycosis causing fungi.
Topics: Animals; Anti-Infective Agents; Bees; COVID-19; Fungi; Humans; Lactobacillales; Mucormycosis; Polyes | 2023 |